Gust H Bardy

Summary

Publications

  1. ncbi request reprint Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103, USA
    N Engl J Med 352:225-37. 2005
  2. doi request reprint Rationale and design of the Home Automatic External Defibrillator Trial (HAT)
    Gust H Bardy
    The Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    Am Heart J 155:445-54. 2008
  3. doi request reprint Home use of automated external defibrillators for sudden cardiac arrest
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    N Engl J Med 358:1793-804. 2008
  4. doi request reprint An entirely subcutaneous implantable cardioverter-defibrillator
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA, USA
    N Engl J Med 363:36-44. 2010
  5. pmc Prognostic importance of defibrillator shocks in patients with heart failure
    Jeanne E Poole
    Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
    N Engl J Med 359:1009-17. 2008
  6. doi request reprint No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial
    Pierre S Aoukar
    University of Washington, Seattle, Washington 98116, USA
    Heart Rhythm 10:970-6. 2013
  7. pmc Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Jay Chen
    University of Washington, Seattle, Washington 98195, USA
    J Am Coll Cardiol 61:2161-8. 2013
  8. pmc Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population
    Wayne C Levy
    Division of Cardiology, University of Washington, Box 356422, 1959 NE Pacific St, Seattle, WA 98195, USA
    Circulation 120:835-42. 2009
  9. ncbi request reprint Key clinical insights from the sudden cardiac death in heart failure trial
    Jill Anderson
    Clinical Affairs, Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    J Cardiovasc Nurs 21:463-8. 2006
  10. doi request reprint No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Joseph A Blatt
    Department of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, Washington 98195, USA
    J Am Coll Cardiol 52:551-6. 2008

Detail Information

Publications23

  1. ncbi request reprint Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103, USA
    N Engl J Med 352:225-37. 2005
    ..Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients...
  2. doi request reprint Rationale and design of the Home Automatic External Defibrillator Trial (HAT)
    Gust H Bardy
    The Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    Am Heart J 155:445-54. 2008
    ..The results of the trial should be available in mid 2008...
  3. doi request reprint Home use of automated external defibrillators for sudden cardiac arrest
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    N Engl J Med 358:1793-804. 2008
    ..Consequently, home use of an automated external defibrillator (AED) might offer an opportunity to improve survival for patients at risk...
  4. doi request reprint An entirely subcutaneous implantable cardioverter-defibrillator
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA, USA
    N Engl J Med 363:36-44. 2010
    ..To eliminate the need for venous access, we designed and tested an entirely subcutaneous ICD system...
  5. pmc Prognostic importance of defibrillator shocks in patients with heart failure
    Jeanne E Poole
    Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
    N Engl J Med 359:1009-17. 2008
    ..e., prevention of a first life-threatening arrhythmic event) may later receive therapeutic shocks from the ICD. Information about long-term prognosis after ICD therapy in such patients is limited...
  6. doi request reprint No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial
    Pierre S Aoukar
    University of Washington, Seattle, Washington 98116, USA
    Heart Rhythm 10:970-6. 2013
    ..SVC coils increase lead complexity, cost, risk of lead failure, and lead removal...
  7. pmc Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Jay Chen
    University of Washington, Seattle, Washington 98195, USA
    J Am Coll Cardiol 61:2161-8. 2013
    ..The aim of this study was to examine rapid-rate nonsustained ventricular tachycardia (RR-NSVT) during routine implantable cardioverter-defibrillator (ICD) evaluation in patients with heart failure and its relationship to outcomes...
  8. pmc Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population
    Wayne C Levy
    Division of Cardiology, University of Washington, Box 356422, 1959 NE Pacific St, Seattle, WA 98195, USA
    Circulation 120:835-42. 2009
    ..Although implantable cardioverter-defibrillator (ICD) therapy reduces mortality in moderately symptomatic heart failure patients with an ejection fraction <or=35%, many such patients do not require ICD shocks over long-term follow-up...
  9. ncbi request reprint Key clinical insights from the sudden cardiac death in heart failure trial
    Jill Anderson
    Clinical Affairs, Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    J Cardiovasc Nurs 21:463-8. 2006
    ..In addition, future directions in the evaluation and management of patients with moderate to severe HF are addressed...
  10. doi request reprint No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Joseph A Blatt
    Department of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, Washington 98195, USA
    J Am Coll Cardiol 52:551-6. 2008
    ..This study investigated whether defibrillation threshold (DFT) testing during implantable cardioverter-defibrillator (ICD) implantation predicts clinical outcomes...
  11. doi request reprint Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    J Am Coll Cardiol 51:1277-82. 2008
    ..The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely...
  12. pmc Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Judith E Mitchell
    State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    Am Heart J 155:501-6. 2008
    ..The purpose of this report is to describe the outcomes in African Americans (AAs) and other minorities...
  13. pmc Quality of life with defibrillator therapy or amiodarone in heart failure
    Daniel B Mark
    Outcomes Research Group, Duke University Medical Center, Durham, NC, USA
    N Engl J Med 359:999-1008. 2008
    ..However, whether this increased longevity is accompanied by deterioration in the quality of life is unclear...
  14. ncbi request reprint Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Am Heart J 153:1089-94. 2007
    ..In the SCD-HeFT, mortality of patients with CHF was assessed after randomization to an implantable cardioverter/defibrillator (ICD), amiodarone, or placebo. The aim of this study was to evaluate the location of deaths in SCD-HeFT...
  15. ncbi request reprint Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation
    Alessandro Capucci
    Division of Cardiology, Gugliemo da Saliceto Hospital, Piacenza, Italy
    Circulation 106:1065-70. 2002
    ..To improve public access to early defibrillation, we established Piacenza Progetto Vita (PPV), the first system of out-of-hospital early defibrillation by first-responder volunteers...
  16. ncbi request reprint Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
    Sana M Al-Khatib
    The Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 149:1020-34. 2005
    ..This document summarizes the evidence reviewed at that meeting and the discussions of that evidence...
  17. ncbi request reprint Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Daniel B Mark
    Outcomes Research Group, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 114:135-42. 2006
    ..We examined long-term economic implications of these results...
  18. ncbi request reprint Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure
    Steven N Singh
    Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am Heart J 152:974.e7-11. 2006
    ..The aim of the study was to determine the role of amiodarone or implantable cardioverter/defibrillator (ICD) in patients with AF and heart failure...
  19. ncbi request reprint Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Ronald S Freudenberger
    Department of Medicine, Robert Wood Johnson Medical School, Suite 6100, 125 Paterson St, New Brunswick, NJ 08903, USA
    Circulation 115:2637-41. 2007
    ..In the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), 2521 patients with moderate heart failure were randomized to receive amiodarone, implanted cardioverter-defibrillators (ICDs), or placebo...
  20. ncbi request reprint Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Michael G Dickinson
    Thoracic Cardiovascular Institute Foundation, Lansing, MI, USA
    Am Heart J 153:573-8. 2007
    ..The study length, size, and degree of background HF, including the use of implantable defibrillator therapy, provide a unique opportunity to evaluate the impact of statin use in HF with mechanistic insights from subgroup analyses...
  21. pmc Absence of bilateral vision loss from amiodarone: a randomized trial
    Joel S Mindel
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am Heart J 153:837-42. 2007
    ..The object of this study was to determine the incidence, dose, and time until onset of bilateral vision loss from amiodarone as a secondary end point in an investigation of amiodarone's role in preventing sudden death...
  22. ncbi request reprint Dynamic pressure--flow velocity relationships in the human cerebral circulation
    Rune Aaslid
    Department of Neurological Surgery, University of Washington School of Medicine, University of Washington Medical Center, Harborview Medical Center, Seattle 98104, USA
    Stroke 34:1645-9. 2003
    ..The time interval before defibrillation enabled calculation of CCP from data in which flow approached zero. These estimates were compared with values calculated before and after fibrillation and during regular heartbeats...
  23. ncbi request reprint Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial
    Richard L Page
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9047, USA
    J Am Coll Cardiol 39:1956-63. 2002
    ..This study compared a biphasic waveform with a conventional monophasic waveform for cardioversion of atrial fibrillation (AF)...